---
title: "Jupiter Neurosciences jumps 4% on $100M drug licensing deal"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293369596.md"
description: "Jupiter Neurosciences rose nearly 4% after securing US rights to neuroprotective candidate ALA-002 in a deal worth up to $100M."
datetime: "2026-07-21T17:01:15.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293369596.md)
  - [en](https://longbridge.com/en/news/293369596.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293369596.md)
---

# Jupiter Neurosciences jumps 4% on $100M drug licensing deal

Jupiter Neurosciences(JUNS.US) 盘中涨近 4%，现报 0.1711 美元。该股当日实际涨幅为 3.70%，5 分钟内快速拉升触发异动警报。

消息面上，公司于 7 月 21 日宣布获得神经保护候选药物 ALA-002 在美国的独家权利，交易总价值最高可达 1 亿美元。此次授权协议标志着公司在神经系统疾病治疗领域的重要布局，资金对此作出积极反应。

### Related Stocks

- [JUNS.US](https://longbridge.com/en/quote/JUNS.US.md)

## Related News & Research

- [PharmAla net loss narrows to CAD 499,759 in Q3 FY26; revenue more than doubled to CAD 513,000](https://longbridge.com/en/news/294356612.md)
- [Jupiter Neurosciences Delays Annual 10-K Filing](https://longbridge.com/en/news/281440517.md)